Strengthening immunity in children aged 0 to 5 in Côte d’Ivoire with the nOPV2 Vaccine
-
by
AFENET
The first round of Côte d’Ivoire’s 2025 vaccination campaign against circulating vaccine-derived poliovirus type 2 (cVDPV2) took place from February 28 to March 3, 2025. The campaign aimed to immunize 9,712,691 children aged 0 to 5 years across 113 districts, ensuring each child received two drops of the novel oral polio vaccine type 2 (nOPV2).
AFENET, with financial support from the US CDC, provided technical assistance by deploying a polio consultant and 10 Field Epidemiology Training Program (FETP) graduates to support activities in 10 health districts in Abidjan. Additionally, AFENET’s polio coordinator for French-speaking countries participated in supervision efforts in Koumassi and Yopougon.
In collaboration with the Côte d’Ivoire Ministry of Health and Expanded Program on Immunization (EPI) partners, AFENET’s team played a crucial role in:
- Training local supervisors and vaccinators to enhance campaign effectiveness.
- Coordinating the transportation of vaccine logistics to ensure timely delivery.
- Supervising field vaccinators to maintain high vaccination quality and coverage.
Through these efforts, AFENET contributed to strengthening polio immunity among Côte d’Ivoire’s youngest population, supporting the country’s fight against cVDPV2.
